CAS No.: 497223-28-6
Cenicriviroc Mesylate Catalog No. CSN26606
Synonyms: TAK-652 Mesylate;TBR-652 Mesylate;TAK-652
Cenicriviroc, also known as TAK-652 and TBR-652, is an experimental drug candidate for the treatment of HIV infection. It is being developed by Takeda Pharmaceutical and Tobira Therapeutics. Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell. Inhibition of CCR2 may have an anti-inflammatory effect.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 497223-28-6 | 储存条件 |
|
|
| 分子式 | C42H56N4O7S2 | 运输 | 蓝冰 | |
| 分子量 | 793.05 | 别名 | TAK-652 Mesylate;TBR-652 Mesylate;TAK-652;TBR-652;Cenicriviroc |
